Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
NCT00778388
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
157
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
IC43
DRUG:
Placebo
Sponsor
Valneva Austria GmbH